Venrock Healthcare Capital Partners II, L.P.

Insider Buys Quantity –
1
2019-03-18SaleKalVista Pharmaceuticals, Inc.
KALV
10 percent owner
1M
6.3285%
$28.75$28.75M-37.83%
2014-08-05PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
800,000
2.6781%
$17.00$13.6M+58.36%